A Regulatory Roadmap for Repurposing: Comparing Pathways for Making Repurposed Drugs Available In The EU, UK, And US
Journal of Law, Medicine & Ethics · 2024 · 52 (4) · 940-949
DOI: 10.1017/jme.2024.171 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Journal of Law, Medicine & Ethics, online erschienen am 31.01.2025. Verfasst von Mirre Scholte und 6 weiteren Autor:innen. Beteiligte Einrichtung: DEPARTMENT OF CLINICAL EPIDEMIOLOGY & MEDICAL TECHNOLOGY ASSESSMENT (KEMTA), MAASTRICHT UNIVERSITY MEDICAL CENTRE, MAASTRICHT, THE NETHERLANDS. Hauptthemen laut MEDLINE: Drug Repositioning, Drug Approval, United States Food and Drug Administration, European Union. Die Arbeit wurde bisher 8-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Health and Digital Executive Agency.
Abstract (Originalsprache)
To help academic and non-profit investigators interested in drug repurposing navigate regulatory approval processes, we compared pathways for repurposed drugs to obtain approval at EMA, UK MHRA, and the US FDA. Though we found no pathways specifically for repurposed drugs, pathways to market are available in all repurposing scenarios.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- DEPARTMENT OF CLINICAL EPIDEMIOLOGY & MEDICAL TECHNOLOGY ASSESSMENT (KEMTA), MAASTRICHT UNIVERSITY MEDICAL CENTRE, MAASTRICHT, THE NETHERLANDS.
- CARE AND PUBLIC HEALTH RESEARCH INSTITUTE (CAPHRI), MAASTRICHT UNIVERSITY, MAASTRICHT, THE NETHERLANDS.
- DEPARTMENTS OF IQ HEALTH & RADIOLOGY, RADBOUDUMC, NIJMEGEN, THE NETHERLANDS.
- PROGRAM ON REGULATION, THERAPEUTICS, AND LAW (PORTAL), DIVISION OF PHARMACOEPIDEMIOLOGY AND PHARMACOECONOMICS, DEPARTMENT OF MEDICINE, BRIGHAM & WOMEN'S HOSPITAL/HARVARD MEDICAL SCHOOL, BOSTON, MASSACHUSETTS, USA.
- REGULATORY AFFAIRS DEPARTMENT, 3D-PHARMXCHANGE, TILBURG, THE NETHERLANDS.
ORCID-Profile: Mirre Scholte, Liam Bendicksen
Förderung
- European Health and Digital Executive Agency
Zitieren
APA
Scholte, M., Bendicksen, L., Grimm, S. E., Abu-Zahra, T., Pauly, B., Joore, M., & Kesselheim, A. S. (2024). A Regulatory Roadmap for Repurposing: Comparing Pathways for Making Repurposed Drugs Available In The EU, UK, And US. Journal of Law, Medicine & Ethics, 52(4), 940-949. https://doi.org/10.1017/jme.2024.171
Vancouver
Scholte M, Bendicksen L, Grimm SE, Abu-Zahra T, Pauly B, Joore M, et al. A Regulatory Roadmap for Repurposing: Comparing Pathways for Making Repurposed Drugs Available In The EU, UK, And US. Journal of Law, Medicine & Ethics. 2024;52(4):940-949. doi:10.1017/jme.2024.171
BibTeX
@article{Scholte2024,
author = {Scholte, Mirre and Bendicksen, Liam and Grimm, Sabine E and Abu-Zahra, Teebah and Pauly, Bianca and Joore, Manuela and Kesselheim, Aaron S},
title = {A Regulatory Roadmap for Repurposing: Comparing Pathways for Making Repurposed Drugs Available In The EU, UK, And US},
journal = {Journal of Law, Medicine & Ethics},
year = {2024},
volume = {52},
number = {4},
pages = {940--949},
doi = {10.1017/jme.2024.171}
}
EUVIMED